Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways
about
ZNF703 gene amplification at 8p12 specifies luminal B breast cancerCo-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisTC-1 overexpression promotes cell proliferation in human non-small cell lung cancer that can be inhibited by PD173074.Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells.ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways.KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancerTransforming properties of 8p11-12 amplified genes in human breast cancer.The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisKnockdown of TC-1 enhances radiosensitivity of non-small cell lung cancer via the Wnt/β-catenin pathwayFunctional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death.Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Thyroid cancer 1 (C8orf4) shows high expression, no mutation and reduced methylation level in lung cancers, and its expression correlates with β-catenin and DNMT1 expression and poor prognosisHuman Thyroid Cancer-1 (TC-1) is a vertebrate specific oncogenic protein that protects against copper and pro-apoptotic genes in yeast.TC-1 (C8orf4) expression is correlated with differentiation in ovarian carcinomas and might distinguish metastatic ovarian from metastatic colorectal carcinomas.The high expression of TC1 (C8orf4) was correlated with the expression of β-catenin and cyclin D1 and the progression of squamous cell carcinomas of the tongue.
P2860
Q24293333-624B4E9D-D938-4970-A717-FD2C7982FE9BQ24655172-B85C87EC-3B26-4173-9B53-3E6007396222Q33773648-CF746498-272E-492E-85E7-55AB4DA25939Q33855516-6334EA22-0E51-42AA-93EA-EE1FEFF60DD6Q34297659-783BB458-2390-4382-BAA5-87238130F260Q34528297-1034F156-4C37-45C4-90CE-D2B204E04D4BQ34950377-13F40834-FB5E-4421-8458-1A22DCD6A632Q35845715-4A0382F6-DD06-412C-A46C-1E454F3C3EFFQ36661876-2F538B90-9EC3-4080-99E5-EE75525E8AD0Q36961435-BB37055E-8272-460D-9DFB-203388DEADFFQ37392664-9A761465-801F-4746-AE68-AEDB741778A9Q38057660-6FFA5D6D-74DC-4722-9AD0-098FD05A56A8Q41866524-E9B9811D-88D2-49F3-95D7-35AAAC9335B7Q42316607-F5D9C8AB-EFE1-4B3A-8061-DEA73671C33DQ43675526-565D5F1B-FA5E-498F-A35B-C796AC0EFDA0Q53546333-268DABBE-AE1E-4E7C-A702-4E4C55D36826
P2860
Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Transforming properties of TC- ...... eta-catenin signaling pathways
@ast
Transforming properties of TC- ...... eta-catenin signaling pathways
@en
Transforming properties of TC- ...... eta-catenin signaling pathways
@nl
type
label
Transforming properties of TC- ...... eta-catenin signaling pathways
@ast
Transforming properties of TC- ...... eta-catenin signaling pathways
@en
Transforming properties of TC- ...... eta-catenin signaling pathways
@nl
prefLabel
Transforming properties of TC- ...... eta-catenin signaling pathways
@ast
Transforming properties of TC- ...... eta-catenin signaling pathways
@en
Transforming properties of TC- ...... eta-catenin signaling pathways
@nl
P2093
P2860
P3181
P356
P1476
Transforming properties of TC- ...... eta-catenin signaling pathways
@en
P2093
Allison B Moffa
Katie L Streicher
Ramsi Haddad
Stephen P Ethier
Zeng-Quan Yang
P2860
P304
P3181
P356
10.1002/IJC.22831
P407
P577
2007-09-15T00:00:00Z